Standalone Audited Financial Result for the quarter and year ended on 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Achyut Healthcare reported revenue from operations of ₹1,159.47 Lakhs for FY26, a massive jump of 280% compared to ₹304.75 Lakhs in FY25. However, net profit declined to ₹31.57 Lakhs from ₹51.47 Lakhs in the previous year (a 39% drop). The company transitioned to Indian Accounting Standards (Ind AS) for the first time this year after migrating from SME to Main Board of BSE in January 2026. Q4 standalone revenue was ₹438.64 Lakhs. The auditor issued an unmodified opinion with an Emphasis of Matter paragraph noting the Ind AS transition. The company also reported related party transactions for the half year ended March 2026.
While revenue surged significantly driven by increased pharmaceutical business activity, the decline in profit margins and lower PAT compared to last year may concern investors. The Ind AS transition and the auditors' unmodified opinion indicate no material concerns about financial reporting quality.